Morphochem
Focuses on finding therapeutic agents to treat cancer and infectious diseases, with particular emphasis on enzyme inhibitors based in Muenchen, Germany.
Mountain View Pharmaceuticals, Inc.
Leader in the biopharmaceutical drug delivery field, with technology of apply its polymer coupling technology platforms and advanced analytical methods.
Mpex Pharmaceuticals, Inc.
Specializes in combining inhibitors of bacterial resistance with proven antibiotics to treat serious infections. Based in San Diego, California.
Myriad Pharmaceuticals
Biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies. Services include drug discovery, gene discovery and genetic testing.
Nanobac Life Sciences
Research, diagnostics and pharmaceutical development related to nanobacterial infectious disease.
Nanotherapeutics, Inc.
A company focuses on developing nano-scale inhaled, nasal, injectable, and oral delivery systems for improved drug therapies base Alachua, Florida
NCE Development - Dr Reddy's
Dr Reddy's custom pharmaceutical services provides medicinal chemistry, process R & D and CGMP scale-up, formulation development and CGMP scale-up for clinical trials.
Neurochem Inc.
Researches and develops compounds that inhibit the formation, deposition and toxic effects of amyloid fibrils within the body.
NeuroTargets Ltd.
Discovery and marketing of medications for inflammation and neuropathic pain. Features company profile and details of technology platform. Guildford, Surrey, United Kingdom.
Neurotech Co., Ltd.
Neurotech Pharmaceuticals, founded in Apr.1998, aims to develop and invent Novel lead compounds that will threaten diseases associated with brain disorders and mal-functional retardances.
Novirio Pharmaceuticals Limited
A independent biopharmaceutical company engaged in the discovery and development of pharmaceuticals for the treatment of life threatening human viral diseases.
NovoBiotic Pharmaceuticals LLC.
Antibiotic discovery, using proprietary technology as a platform, for growing previously unculturable microorganisms in the laboratory. Includes publications, related news, and careers in Cambridge, Massachusetts.
Novogen Ltd.
Discovers, develops, manufactures and markets isoflavonoids for menopausal non-prescription drugs, and multiple signal transduction regulator drugs for cancer. Includes technological overview, and history of company, with offices in Europe and North America, and headquarters in North Ryde, New South Wales. (Nasdaq: NVGN)
Oasmia Pharmaceutical
Development of techniques to focus the release of cytostatics to tumour tissue based in Uppsala, Sweden.
Oculus Innovative Sciences
Developer of Microcyn 60 disinfectant, L3 oncology compound and drug-eluting stents along with other disruptive health care technologies.
Oncopharm Corporation
Involved in research, development and production of new antileukemic drugs.
Oridis Biomed
A research-oriented biotechnology company gaining new insights into ORIgins of DISeases with genomic and proteomic investigation of human diseased tissues. The company will develop new diagnostic and therapeutic targets and substances.
Oscient Pharmaceuticals
Develops and markets new compounds including antibiotics. Features investor information and product details. Waltham, Massachusetts, USA.
Palumed S.A.
Pharmaceutical company developing novel antimalarial drugs candidates against resistant strains of Plasmodium falciparum.
PanTherix Ltd
Using leading technologies in structural enzymology to discover and develop drugs for fighting infectious diseases.
Results: Previous 1 2 3 4 5 6 7 8 9 10 Next
Site
Menu 
